Royal Bank Of Canada Forte Biosciences, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$0.48 - $0.85 $65 - $116	137 New	137 $0
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.11 $16 - $18	-17 Reduced 9.88%	155 $0
Q1 2023 May 15, 2023	BUY	$0.98 - $1.06 $5 - $6	6 Added 3.61%	172 $0
Q4 2022 Feb 14, 2023	SELL	$0.96 - $28.0 $60 - $1,764	-63 Reduced 27.51%	166 $0
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.75 $46 - $1,221	44 Added 23.78%	229 $0
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $1,212 - $1,756	-1,133 Reduced 85.96%	185 $0
Q1 2022 May 16, 2022	SELL	$1.21 - $2.24 $2,084 - $3,859	-1,723 Reduced 56.66%	1,318 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.02 - $3.36 $3,801 - $6,323	1,882 Added 162.38%	3,041 $7,000
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $1,145 - $14,191	387 Added 50.13%	1,159 $4,000
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $24,318 - $32,810	772 New	772 $26,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.